US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.5900
  • -0.0080-1.34%
Close Nov 29 13:00 ET
  • 0.5708
  • -0.0192-3.25%
Post 16:49 ET
4.01MMarket Cap-464P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-54.46%652.07K
45.78%1.67M
135.14%1.74M
27.24%4.53M
84.85%1.21M
54.94%1.43M
79.64%1.14M
-44.88%739.29K
-14.07%3.56M
-23.85%655.78K
Selling and administrative expenses
-6.44%287.88K
47.48%453.3K
-29.05%277.61K
-38.68%1.21M
-49.58%200.8K
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-34.46%1.97M
-44.27%398.26K
-General and administrative expense
-6.44%287.88K
47.48%453.3K
-29.05%277.61K
-38.68%1.21M
-49.58%200.8K
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-34.46%1.97M
-44.27%398.26K
Research and development costs
-67.60%364.18K
45.16%1.21M
319.72%1.46M
108.90%3.32M
292.76%1.01M
124.19%1.12M
421.06%836.38K
-48.04%348.03K
39.80%1.59M
75.70%257.52K
Operating profit
54.46%-652.07K
-45.78%-1.67M
-135.14%-1.74M
-27.24%-4.53M
-84.85%-1.21M
-54.94%-1.43M
-79.64%-1.14M
44.88%-739.29K
14.07%-3.56M
23.85%-655.78K
Net non-operating interest income expense
-69.72%11.28K
-82.50%9.29K
-45.90%13.87K
224.40%156.79K
-32.52%40.81K
253.55%37.26K
881.20%53.1K
261.43%25.63K
110.42%48.33K
326.63%60.47K
Non-operating interest income
-83.70%11.28K
-89.03%9.29K
-75.63%13.87K
42.35%264.48K
-41.95%53.66K
62.88%69.22K
157.47%84.71K
216.65%56.89K
459.49%185.79K
183.18%92.43K
Non-operating interest expense
--0
--0
--0
-21.66%107.68K
-59.78%12.85K
0.00%31.96K
-20.37%31.61K
-7.63%31.26K
-72.34%137.46K
-46.13%31.96K
Other net income (expense)
143.33%51.53K
104.47%198
-1,268.74%-630.32K
-8,222.56%-504.76K
81.54%-2.18K
-411.69%-118.95K
10.57%-4.43K
-156.72%-46.05K
-143.97%-6.07K
Gain on sale of security
----
143.33%51.53K
104.47%198
-1,268.74%-630.32K
-7,876.31%-483.76K
-96.66%-23.18K
-411.69%-118.95K
10.57%-4.43K
-156.72%-46.05K
-143.97%-6.07K
Other non- operating income (expenses)
----
----
----
----
----
--21K
----
----
----
----
Income before tax
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
Net income continuous Operations
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
Minority interest income
Net income attributable to the parent company
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
Basic earnings per share
56.25%-0.14
-28.57%-0.36
-129.41%-0.39
-40.24%-1.15
-171.43%-0.38
-52.38%-0.32
-86.67%-0.28
46.88%-0.17
33.87%-0.82
30.00%-0.14
Diluted earnings per share
56.25%-0.14
-28.57%-0.36
-129.41%-0.39
-40.24%-1.15
-171.43%-0.38
-52.38%-0.32
-86.67%-0.28
46.88%-0.17
33.87%-0.82
30.00%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -54.46%652.07K45.78%1.67M135.14%1.74M27.24%4.53M84.85%1.21M54.94%1.43M79.64%1.14M-44.88%739.29K-14.07%3.56M-23.85%655.78K
Selling and administrative expenses -6.44%287.88K47.48%453.3K-29.05%277.61K-38.68%1.21M-49.58%200.8K-27.21%307.68K-35.45%307.36K-41.73%391.26K-34.46%1.97M-44.27%398.26K
-General and administrative expense -6.44%287.88K47.48%453.3K-29.05%277.61K-38.68%1.21M-49.58%200.8K-27.21%307.68K-35.45%307.36K-41.73%391.26K-34.46%1.97M-44.27%398.26K
Research and development costs -67.60%364.18K45.16%1.21M319.72%1.46M108.90%3.32M292.76%1.01M124.19%1.12M421.06%836.38K-48.04%348.03K39.80%1.59M75.70%257.52K
Operating profit 54.46%-652.07K-45.78%-1.67M-135.14%-1.74M-27.24%-4.53M-84.85%-1.21M-54.94%-1.43M-79.64%-1.14M44.88%-739.29K14.07%-3.56M23.85%-655.78K
Net non-operating interest income expense -69.72%11.28K-82.50%9.29K-45.90%13.87K224.40%156.79K-32.52%40.81K253.55%37.26K881.20%53.1K261.43%25.63K110.42%48.33K326.63%60.47K
Non-operating interest income -83.70%11.28K-89.03%9.29K-75.63%13.87K42.35%264.48K-41.95%53.66K62.88%69.22K157.47%84.71K216.65%56.89K459.49%185.79K183.18%92.43K
Non-operating interest expense --0--0--0-21.66%107.68K-59.78%12.85K0.00%31.96K-20.37%31.61K-7.63%31.26K-72.34%137.46K-46.13%31.96K
Other net income (expense) 143.33%51.53K104.47%198-1,268.74%-630.32K-8,222.56%-504.76K81.54%-2.18K-411.69%-118.95K10.57%-4.43K-156.72%-46.05K-143.97%-6.07K
Gain on sale of security ----143.33%51.53K104.47%198-1,268.74%-630.32K-7,876.31%-483.76K-96.66%-23.18K-411.69%-118.95K10.57%-4.43K-156.72%-46.05K-143.97%-6.07K
Other non- operating income (expenses) ----------------------21K----------------
Income before tax 54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K
Income tax 0000000000
Net income 54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K
Net income continuous Operations 54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K
Minority interest income
Net income attributable to the parent company 54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K
Basic earnings per share 56.25%-0.14-28.57%-0.36-129.41%-0.39-40.24%-1.15-171.43%-0.38-52.38%-0.32-86.67%-0.2846.88%-0.1733.87%-0.8230.00%-0.14
Diluted earnings per share 56.25%-0.14-28.57%-0.36-129.41%-0.39-40.24%-1.15-171.43%-0.38-52.38%-0.32-86.67%-0.2846.88%-0.1733.87%-0.8230.00%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data